SCHEMBL4649202

SCHEMBL4649202

CC(C)(C)OC(=O)Nc1cc2c(cc1F)CN(COCC[Si](C)(C)C)CC2=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.35
PRMT5 O14744 2/20 0.34
WDR77 Q9BQA1 2/20 0.34
GPR119 Q8TDV5 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
CNR2 P34972 1/20 0.33
DRD2 P14416 2/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
ABL1 P00519 1/20 0.31
SRC P12931 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
AR P10275 2/20 0.30
RORC P51449 3/20 0.30
MIF P14174 1/20 0.30
BRAF P15056 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24195934 0.74 CYP17A1 (0.39) CYP17A1CNR2BRAFP2RX3
SCHEMBL5420207 0.72 CYP17A1 (0.37) CYP17A1CNR2CA12CA1CA9
SCHEMBL4649319 0.69 ALDH1A1 (0.44) DRD2
SCHEMBL943944 0.66 CYP17A1 (0.33) CYP17A1CD274
SCHEMBL25901668 0.64 IDO1 (0.34) PRMT5WDR77CNR2DRD2ABL1
SCHEMBL14725520 0.64 CYP17A1 (0.48) CYP17A1GPR119CNR2CA12CA1
SCHEMBL26112645 0.64 DRD2 (0.43) CYP17A1PRMT5WDR77DPP8DPP9
SCHEMBL25321588 0.64 CYP17A1 (0.33) CYP17A1
SCHEMBL24509637 0.63 CYP17A1 (0.39) CYP17A1CD274
SCHEMBL31064570 0.63 TP53 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667989-A4 SUBSTITUTED ISOQUINOLINONES PORTOLA PHARM INC (US) 2008-08-20 EP disclosed
EP-1667989-A1 SUBSTITUTED ISOQUINOLINONES Portola Pharmaceuticals, Inc. (US) 2006-06-14 EP disclosed
WO-2005035520-A1 SUBSTITUTED ISOQUINOLINONES PORTOLA PHARMACEUTICALS, INC. (US) 2005-04-21 WO disclosed